JavaScript is disabled for your browser. Some features of this site may not work without it.
Statistics
Total Visits
| Views | |
|---|---|
| Tisagenlecleucel (chimeric antigen receptor T-cells targeting CD19) for patients with relapsed/refractory B-cell acute lymphoblastic leukemia: asystematic review and cost-utility analysis from a Spanish perspective | 237 |
Total Visits Per Month
| June 2023 | July 2023 | August 2023 | September 2023 | October 2023 | November 2023 | December 2023 | |
|---|---|---|---|---|---|---|---|
| Tisagenlecleucel (chimeric antigen receptor T-cells targeting CD19) for patients with relapsed/refractory B-cell acute lymphoblastic leukemia: asystematic review and cost-utility analysis from a Spanish perspective | 3 | 3 | 2 | 2 | 0 | 4 | 3 |
File Visits
| Views | |
|---|---|
| Delgado_Tisagenlecleucel_MUESIOL.pdf | 93 |
Top country views
| Views | |
|---|---|
| United States | 86 |
| Spain | 50 |
| Germany | 20 |
| France | 6 |
| Brazil | 5 |
| Saudi Arabia | 5 |
| United Kingdom | 4 |
| Sweden | 4 |
| Austria | 3 |
| Colombia | 3 |
Top cities views
| Views | |
|---|---|
| San Ramon | 25 |
| Barcelona | 17 |
| Madrid | 13 |
| Redwood City | 12 |
| Hamburg | 7 |
| Fremont | 6 |
| Piracicaba | 4 |
| Blue Bell | 3 |
| Bogotá | 3 |
| Granada | 3 |
